abstract |
The invention relates to compounds which are represented by the general formula (I) wherein R?1, R2, R3¿ and n are as defined in the specification. The invention further relates to medicaments containing these compounds and to a process for their preparation. The compounds possess affinity towards metabotropic glutamate receptors and are therefore useful in the treatment or prevention of acute and/or chronic neurological disorders. |